Increased plasma levels of sCD163 have been linked to states of low-grade inflammation such as diabetes, obesity, liver disease, tuberculosis, and atherosclerosis [32,33,34,35,36]. This evidence concerns the gene CD163 and obesity due to melanocortin 4 receptor deficiency.